Orilissa

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
NDA210450 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Orilissa Is Indicated For The Management Of Moderate To Severe Pain Associated With Endometriosis. Orilissa Is A Gonadotropin-Releasing Hormone (Gnrh) Receptor Antagonist Indicated For The Management Of Moderate To Severe Pain Associated With Endometriosis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Elagolix Sodium ELAGOLIX SODIUM ZINC49888891

Comments